|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q62583693
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010849.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q62583693
|
|
024
|
|
|
‡a
0000-0002-5444-8076
‡2
orcid
|
|
024
|
|
|
‡a
36070006300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q62583693
|
|
100
|
0 |
|
‡a
Elena Sebastián
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Elena Sebastián
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction
|
|
670
|
|
|
‡a
Author's Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma
|
|
670
|
|
|
‡a
Author's Extracorporeal photopheresis in paediatric patients: A retrospective comparison between different ‘off‐line’ protocols
|
|
670
|
|
|
‡a
Author's High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
|
|
670
|
|
|
‡a
Author's HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.
|
|
670
|
|
|
‡a
Author's Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic
|
|
670
|
|
|
‡a
Author's Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
|
|
670
|
|
|
‡a
Author's Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.
|
|
670
|
|
|
‡a
Author's MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
|
|
670
|
|
|
‡a
Author's Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation
|
|
670
|
|
|
‡a
Author's Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge
|
|
670
|
|
|
‡a
Author's The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
|
|
909
|
|
|
‡a
(scopus) 36070006300
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000254448076
‡9
1
|
|
919
|
|
|
‡a
useofcd138positivelyselectedmarrowsamplesincreasestheapplicabilityofminimalresidualdiseaseassessmentbypcrinpatientswithmultiplemyeloma
‡A
The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
‡9
1
|
|
919
|
|
|
‡a
systemiclupuserythematosuspresentingasthromboticthrombocytopaenicpurpurainachildadiagnosticchallenge
‡A
Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge
‡9
1
|
|
919
|
|
|
‡a
sustainedcompleteremissionwithsingleagentrituximabinrelapsedfollicularlymphomaastransformeddiseaseafterunrelatedreducedintensityconditioningallogeneicstemcelltransplantation
‡A
Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation
‡9
1
|
|
919
|
|
|
‡a
myd88l265pisamarkerhighlycharacteristicofbutnotrestrictedtowaldenstromsmacroglobulinemia
‡A
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationofimmunoglobulingenerearrangementsindiffuselargebcelllymphomaantigendrivenoriginandighv434asaparticularsubgroupofthenongcbsubtype
‡A
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.
‡9
1
|
|
919
|
|
|
‡a
kappadeletingelementasanalternativemoleculartargetforminimalresidualdiseaseassessmentbyrealtimequantitativepcrinpatientswithmultiplemyeloma
‡A
Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
‡9
1
|
|
919
|
|
|
‡a
initialreportonspanishpediatriconcologichematologicandpoststemcelltransplantationpatientsduringsarscov2pandemic
‡A
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic
‡9
1
|
|
919
|
|
|
‡a
hlaspecificitiesarerelatedtodevelopmentandprognosisofdiffuselargebcelllymphoma
‡A
HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.
‡9
1
|
|
919
|
|
|
‡a
highresolutioncopynumberanalysisofpairednormaltumorsamplesfromdiffuselargebcelllymphoma
‡A
High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
‡9
1
|
|
919
|
|
|
‡a
extracorporealphotopheresisinpaediatricpatientsaretrospectivecomparisonbetweendifferentofflineprotocols
‡A
Extracorporeal photopheresis in paediatric patients: A retrospective comparison between different ‘off‐line’ protocols
‡9
1
|
|
919
|
|
|
‡a
evaluatinggeneexpressionprofilingbyquantitativepolymerasechainreactiontodevelopaclinicallyfeasibletestforoutcomepredictioninmultiplemyeloma
‡A
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma
‡9
1
|
|
919
|
|
|
‡a
detectionofmyd88l265pmutationbyrealtimeallelespecificoligonucleotidepolymerasechainreaction
‡A
Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BNE|XX5153785
|
|
996
|
|
|
‡2
LC|n 2016019262
|
|
996
|
|
|
‡2
LC|n 82016390
|
|
996
|
|
|
‡2
PLWABN|9810697499205606
|
|
996
|
|
|
‡2
ISNI|000000001752336X
|
|
996
|
|
|
‡2
LC|no2012155170
|
|
996
|
|
|
‡2
BNE|XX937285
|
|
996
|
|
|
‡2
DNB|128144440
|
|
996
|
|
|
‡2
BNE|XX4760688
|
|
996
|
|
|
‡2
DNB|1061359484
|
|
996
|
|
|
‡2
BNE|XX6164631
|
|
996
|
|
|
‡2
DNB|130049336
|
|
996
|
|
|
‡2
LC|n 87821460
|
|
996
|
|
|
‡2
BIBSYS|90508959
|
|
996
|
|
|
‡2
BNE|XX4736239
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
